Pharmaceutical Technology on MSN

BMS bets on Janux’s novel solid tumour therapy through $850m deal

This deal marks another addition to BMS’s growing pipeline, which the company hopes will stave off the impacts of the ...

4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer

D Path’s QPOR™ Platform Selected to Predict Patients’ Responses to TherapyNEWTON, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- 4D ...

Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi

Jaguar has received the initial $16M payment related to the company's recently executed US out-license agreement for ...
Frontiers

Mathematical Modeling in Discovery and Analysis of Immune Responses

Uncovering mechanisms regulating immune system responses is key to strengthening and redirecting them whenever necessary in cancer and infections as well as understanding autoimmune diseases. However, ...

Psychedelic medicine tripped, but is now making a comeback: in conversation with Dr. Ayla Sela

Nessa Yip sits down with Dr. Ayla Sela to discuss the possibilities of psychedelic medicine The classic psychedelics – LSD, psilocybin, DMT – are psychoactive compounds known to elicit a repertoire of ...

NICU team at BJMC and Sassoon Hospital identify first genetic link to Transient Neonatal Diabetes

Doctors at the Neonatal Intensive Care Unit (NICU) of B J Government Medical College and Sassoon General Hospital, Pune, have ...